Skip to content
10-Q

Quarterly Report

OSR Health, Inc. OSRH OSRHW

0001213900-26-055492

← back to feed
Filed
May 13, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 10, 2026 35.1M sh
Shares Diluted Q1 2026 · Mar 31, 2026 34.27M sh
Shares Diluted Q1 2026 · Mar 31, 2025 10.91M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$1M
Operating Cash Flow restated Q1 2026 · Mar 31, 2025 −$64.07K
Long Term Debt Q1 2026 · Mar 31, 2026 $272.91K
Short Term Debt Q1 2026 · Mar 31, 2026 $2.22M
Short Term Debt Q1 2026 · Dec 31, 2025 $2.32M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $1.57M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $1.7M
Current Liabilities Q1 2026 · Mar 31, 2026 $17.9M
Current Liabilities Q1 2026 · Dec 31, 2025 $17.17M
Total Liabilities Q1 2026 · Mar 31, 2026 $44.8M
Total Liabilities Q1 2026 · Dec 31, 2025 $44.2M
Current Assets Q1 2026 · Mar 31, 2026 $2.92M
Current Assets Q1 2026 · Dec 31, 2025 $2.82M
Total Assets Q1 2026 · Mar 31, 2026 $172.19M
Total Assets Q1 2026 · Dec 31, 2025 $171.24M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.08
Eps Diluted Q1 2026 · Mar 31, 2025 −$1.04
Eps Basic Q1 2026 · Mar 31, 2026 −$0.09
Eps Basic Q1 2026 · Mar 31, 2025 −$1.04
Sga Expense Q1 2026 · Mar 31, 2026 $3.83M
Sga Expense restated Q1 2026 · Mar 31, 2025 $3.09M
Rd Expense Q1 2026 · Mar 31, 2026 $113.15K
Rd Expense Q1 2026 · Mar 31, 2025 $90.15K
Operating Income Q1 2026 · Mar 31, 2026 −$3.67M
Operating Income restated Q1 2026 · Mar 31, 2025 −$2.92M
Gross Profit Q1 2026 · Mar 31, 2026 $160.28K
Gross Profit restated Q1 2026 · Mar 31, 2025 $168.69K
Cost Of Revenue Q1 2026 · Mar 31, 2026 $323.78K
Cost Of Revenue restated Q1 2026 · Mar 31, 2025 $592.59K
Revenue Q1 2026 · Mar 31, 2026 $484.06K
Revenue Q1 2026 · Mar 31, 2025 $761.27K